Liu Weizhi, MacGrath Stacey M, Koleske Anthony J, Boggon Titus J
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Feb 1;68(Pt 2):154-8. doi: 10.1107/S1744309111056132. Epub 2012 Jan 25.
Crystallization of contaminating proteins is a frequently encountered problem for macromolecular crystallographers. In this study, an attempt was made to obtain a binary cocrystal structure of the SH3 domain of cortactin and a 17-residue peptide from the Arg nonreceptor tyrosine kinase encompassing a PxxPxxPxxP (PxxP1) motif. However, cocrystals could only be obtained in the presence of trace amounts of a contaminating protein. A structure solution obtained by molecular replacement followed by ARP/wARP automatic model building allowed a 'sequence-by-crystallography' approach to discover that the contaminating protein was lysozyme. This 1.65 Å resolution crystal structure determination of a 1:1:1 heterotrimeric complex of Arg, cortactin and lysozyme thus provides an unusual `caveat emptor' warning of the dangers that underpurified proteins harbor for macromolecular crystallographers.
对于大分子晶体学家而言,污染蛋白的结晶是一个经常遇到的问题。在本研究中,我们尝试获得cortactin的SH3结构域与来自Arg非受体酪氨酸激酶的一个包含PxxPxxPxxP(PxxP1)基序的17个残基肽段的二元共晶体结构。然而,只有在存在痕量污染蛋白的情况下才能获得共晶体。通过分子置换和ARP/wARP自动模型构建获得的结构解析,采用“晶体学测序”方法发现污染蛋白是溶菌酶。因此,这个分辨率为1.65 Å的Arg、cortactin和溶菌酶1:1:1异源三聚体复合物的晶体结构测定,为大分子晶体学家提供了一个不同寻常的“买家自负”警告,提醒他们未充分纯化的蛋白所潜藏的危险。